Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 5
2021 6
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
Tanda ET, d'Amato AL, Rossi G, Croce E, Boutros A, Cecchi F, Spagnolo F, Queirolo P. Tanda ET, et al. Among authors: boutros a. Front Oncol. 2021 Sep 23;11:739006. doi: 10.3389/fonc.2021.739006. eCollection 2021. Front Oncol. 2021. PMID: 34631574 Free PMC article. Review.
The treatment of advanced melanoma: Current approaches and new challenges.
Boutros A, Croce E, Ferrari M, Gili R, Massaro G, Marconcini R, Arecco L, Tanda ET, Spagnolo F. Boutros A, et al. Crit Rev Oncol Hematol. 2024 Apr;196:104276. doi: 10.1016/j.critrevonc.2024.104276. Epub 2024 Jan 29. Crit Rev Oncol Hematol. 2024. PMID: 38295889 Free article. Review.
How to Protect Ovarian Function before and during Chemotherapy?
Arecco L, Ruelle T, Martelli V, Boutros A, Latocca MM, Spinaci S, Marrocco C, Massarotti C, Lambertini M. Arecco L, et al. Among authors: boutros a. J Clin Med. 2021 Sep 16;10(18):4192. doi: 10.3390/jcm10184192. J Clin Med. 2021. PMID: 34575299 Free PMC article. Review.
The adjuvant treatment revolution for high-risk melanoma patients.
Spagnolo F, Boutros A, Tanda E, Queirolo P. Spagnolo F, et al. Among authors: boutros a. Semin Cancer Biol. 2019 Dec;59:283-289. doi: 10.1016/j.semcancer.2019.08.024. Epub 2019 Aug 21. Semin Cancer Biol. 2019. PMID: 31445219 Review.
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications.
Vanni I, Tanda ET, Dalmasso B, Pastorino L, Andreotti V, Bruno W, Boutros A, Spagnolo F, Ghiorzo P. Vanni I, et al. Among authors: boutros a. Front Mol Biosci. 2020 Jul 24;7:172. doi: 10.3389/fmolb.2020.00172. eCollection 2020. Front Mol Biosci. 2020. PMID: 32850962 Free PMC article. Review.
Current State of Target Treatment in BRAF Mutated Melanoma.
Tanda ET, Vanni I, Boutros A, Andreotti V, Bruno W, Ghiorzo P, Spagnolo F. Tanda ET, et al. Among authors: boutros a. Front Mol Biosci. 2020 Jul 14;7:154. doi: 10.3389/fmolb.2020.00154. eCollection 2020. Front Mol Biosci. 2020. PMID: 32760738 Free PMC article. Review.
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma.
Boutros A, Cecchi F, Tanda ET, Croce E, Gili R, Arecco L, Spagnolo F, Queirolo P. Boutros A, et al. Front Oncol. 2021 Aug 26;11:733917. doi: 10.3389/fonc.2021.733917. eCollection 2021. Front Oncol. 2021. PMID: 34513710 Free PMC article. Review.
Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma.
Spagnolo F, Croce E, Boutros A, Tanda E, Cecchi F, Mascherini M, Solari N, Cafiero F, Queirolo P. Spagnolo F, et al. Among authors: boutros a. Expert Rev Anticancer Ther. 2020 May;20(5):403-413. doi: 10.1080/14737140.2020.1760847. Epub 2020 May 3. Expert Rev Anticancer Ther. 2020. PMID: 32326767 Review.
19 results